Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means deaths or serious injuries are reported, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Minimum severity
Hospira is recalling Lidocaine Hydrochloride Injection vials because visible particulate matter embedded in the glass wall may dislodge into the product.
Caraco is recalling Tramadol HCl 50 mg tablets because a customer reported finding Metoprolol Tartrate tablets in a bottle.
GlaxoSmithKline is recalling specific lots of Arranon (nelarabine) Injection because drug-related impurities may exceed specification limits.
Ranbaxy Inc. is recalling specific lots of Atorvastatin Calcium tablets because they may contain small glass particulates.
Ranbaxy Inc. is recalling certain lots of Atorvastatin Calcium tablets because they may contain small glass particulates.
Samantha Lynn, Inc. is recalling Reumofan Plus Tablets because they contain undeclared drug ingredients, making them unapproved drugs.
Vintage Pharmaceuticals is recalling 14,445 bottles of hydrocodone and acetaminophen tablets because confirmed complaints found oversized pills with superpotent drug levels.
Watson Laboratories is recalling specific lots of Hydrocodone Bitartrate and Acetaminophen tablets because they may be oversized and superpotent.
Ranbaxy Inc. is recalling 32,208 bottles of Atorvastatin Calcium 10 mg tablets because a 20 mg tablet was found inside a sealed 10 mg bottle.
New England Compounding Center is voluntarily recalling all non-sterile products due to Good Manufacturing Practice (GMP) deviations. The recall covers products distributed nationwide and in Japan.
New England Compounding Center is recalling all of its sterile products because the company cannot assure that the products are sterile.
Aurobindo Pharma is recalling Northstar Zolpidem Tartrate Tablets 10 mg because 30 valacyclovir tablets were found in a bottle.
XRock Industries is recalling X-ROCK For Men dietary supplements because testing revealed the presence of unapproved prescription drug ingredients.
Coral Rock Man, Inc. is recalling Z-ROCK All Natural Male Supplement because testing revealed the presence of Sildenafil and its analogs, which were not approved in the product.
Coral Rock Man, Inc. is recalling X-Rock 3 Day Pill For Men because the product was marketed without an approved NDA/ANDA and tested positive for Sildenafil and analogs.
Hospira is recalling 216,880 units of Hydromorphone Hydrochloride Injection because the prefilled cartridges were found to be overfilled, containing more than the labeled 1 mL volume.
Watson Laboratories is recalling specific lots of Necon 10/11 oral contraceptives because they may contain trace amounts of Hydrochlorothiazide (HCTZ).
Raritan Pharmaceuticals is recalling Premier Value Fiber Capsules due to possible C. difficile contamination found in the raw material.
Raritan Pharmaceuticals is recalling CVS Pharmacy Fiber Capsules due to possible C. difficile contamination found in raw materials.
Raritan Pharmaceuticals is recalling Wal-Mucil Plus Calcium Fiber Capsules due to possible C. difficile contamination found in raw materials.
Raritan Pharmaceuticals is recalling Best Choice Health Care Psyllium Fiber Supplement due to possible C. difficile contamination in raw materials.
Raritan Pharmaceuticals is recalling Equate Fiber Therapy capsules due to possible C. difficile contamination found in raw materials.
Raritan Pharmaceuticals is recalling Premier Value Fiber Plus Calcium Supplement Capsules due to possible C. difficile contamination in raw materials.
Watson Laboratories is recalling Necon 1/35-28 tablets because certain lots may contain trace amounts of Hydrochlorothiazide (HCTZ). The recall covers 6,466 cartons distributed nationwide and in Puerto Rico.
Raritan Pharmaceuticals is recalling specific lots of Wal-Mucil fiber laxative capsules due to possible C. difficile contamination in the raw material.